Author (Corporate) | European Commission: DG Health and Food Safety |
---|---|
Series Details | COM (2021) 355 |
Publication Date | 06/05/2021 |
Content Type | Blog & Commentary, News, Policy-making |
Summary: Communication published by the European Commission on 6 May 2021, setting out a strategy focusing on the development and availability of COVID-19 (coronavirus) therapeutics, including the treatment of the so-called long COVID condition. Further information: The strategy aims to cover the full lifecycle of medicines - from research, development and manufacturing to procurement and deployment. It includes a set of actions and targets on a number of fields:
The strategy is seen as complementary to the EU Vaccines Strategy and part of a strong European Health Union. On 29 June 2021, the European Commission announced the first portfolio of five therapeutics in the framework of this strategy. |
|
Source Link |
Link to Main Source
https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=COM:2021:355:FIN
Alternative sources
|
Related Links |
|
Subject Categories | Health |
Subject Tags | Medicines | Medical Devices |
Keywords | COVID-19 (Coronavirus) |
International Organisations | European Union [EU] |